3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Withdrawn
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
2
Neoplasms
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia
1
Interventions
Cyclophosphamide
9
Radiotherapy
5
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporine
4
fludarabine phosphate
3
Melphalan
3
Indium
3
Filgrastim
3
Dexamethasone
3
sargramostim
2
epratuzumab
2
Radioimmunodetection
2
Paclitaxel
2
Mycophenolic Acid
2
Metronidazole
2
Lym-1 monoclonal antibody
2
Lenalidomide
2
Interferon-alpha
2
Idarubicin
2
Etoposide
2
Cytarabine
2
Clarithromycin
2
Cisplatin
2
Busulfan
2
Antilymphocyte Serum
2
Amoxicillin
2
motesanib diphosphate
1
ledipasvir, sofosbuvir drug combination
1
ibritumomab tiuxetan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, B-Cell, Marginal Zone
×
Pentostatin
×
Clear all
NCT00927797
2009-06-25
PERLL
Heidelberg University
Phase 2
Unknown
185 enrolled